October Newsmakers

October 9, 2018
By: Julie Poucher Harbin, Writer, DCI

Why Are Black Women Less Likely To Stick With A Breast Cancer Follow-Up Treatment? (National Public Radio)
Features Niasha Fray, MA, MSPH

Current Options for Frontline Treatment of CLL (Targeted Oncology)
Features Danielle Brander, MD

Most breast cancer patients want early cost estimates (UPI)
Features Rachel Greenup, MD

Patients Want Breast Cancer Costs Upfront (WebMD)
Features Rachel Greenup, MD

Affluent, Insured, and Worried About Cancer Costs (Medscape)
Features Rachel Greenup, MD

Changing the Culture of Acceptability of Financial Sacrifice in Cancer (Journal of Clinical Pathways)
Features Fumiko Chino, MD

Cancer patients have lower risk of opioid-related death than general public (Cancer Letter)
Features DCI Researchers

Paying for Cancer Care at All Costs (Cure)
Features Fumiko Chino, MD

Opioid Overdose Statistics Among Cancer Population Is Different From General Population (Oncology Nurse Advisor)
Features Fumiko Chino, MD, Juno Chino, MD, and Arif Kamal, MD

Top Doctors and Researchers Headline Paws for a Cure Research Symposium to Seek Cures for Cancers Shared by Dogs and Kids (Oncology Nursing News)
Features Michael Kastan, MD, PhD

CRISPR-Cas9 Could Inhibit Anal Cancer Tumor Growth In vivo (Synthego)
Features David Hsu, MD, PhD; Anand VR Kornepati; Wayne Glover; Edward M. Kennedy, PhD; and Bryan Cullen, PhD  

DNA damage and mutations across the genome (Environmental Factor/NIEHS/NIH)
Features Ed Levin, PhD, and Natalie Saini, PhD

WATCH: What is the best front line treatment for metastatic clear cell RCC in 2018? (KidneyCancer.org)
Features Michael Harrison, MD

Development and Validation of a Prognostic Model for Overall Survival in Chemotherapy-Naïve Men with Metastatic Castration-Resistant Prostate Cancer (UroToday)
Features Andrew Armstrong, MD

mCRPC agent’s efficacy differs depending on race (Urology Times)
Features Daniel George, MD

From death penalty scholar to cellist, meet Duke's newest faculty members (The Chronicle)
Features Marc Ryser, PhD

Duke researchers earn $2 million National Science Foundation grant for cancer research using CRISPR (The Chronicle)
Features Charles Gersbach, PhD

Duke University Hospital tops physicians’ choice for neurological conditions (Duke School of Medicine, Dept. of Neurology)


Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC. Elsevier. November 2018. Bradley G.Ackerson, Betty C.Tong, Julian C.Hong, Lin Gu, Junzo Chino, Jacob W.Trotter, Thomas A.D’Amico, Jordan A.Torok, Kyle Lafata, Catherine Chang, Chris R Kelsey.

Targeting HPV16 DNA using CRISPR/Cas inhibits anal cancer growth in vivo. Future Virology. July 2018. David Hsu; Anand VR Kornepati; Wayne Glover; Edward M. Kennedy; and Bryan Cullen